Mode of action of lipid-lowering drugs.

  • Robin Fears
  • Published 1987 in Bailliere's clinical endocrinology and metabolism


Following the recent demonstration that both cholestyramine and nicotinic acid decrease mortality from coronary heart disease, there is a new enthusiasm for hypolipidaemic therapy. The agents in current use are, however, insufficiently active or are accompanied by unacceptable side effects. An understanding of the mode of action is necessary, both to… (More)


  • Presentations referencing similar topics